N6-methyladenosine Modifications in Cervical Cancer: The Molecular and Clinical Perspective

Ziqi Xu

2025

Abstract

N6-methyladenosine (m6A) is closely associated with cervical cancer. m6A is responsible for the stability, transport, and splicing of RNA, which regulates apoptosis, cell proliferation, RNA metabolism, the tumor immune microenvironment, and metastasis. The m6A modification process is found in both mRNA and non-coding RNAs (ncRNAs). A group of enzymes called writers, erasers, and readers are involved in controlling m6A.These enzymes act as oncogene promoters in cervical cancer by upregulating or downregulating oncogenes. m6A modifications hold future potential to be used as biomarkers. Several drugs and inhibitors targeting m6A modulators have been discovered. This review explores the molecular mechanisms of m6A modifications, as well as their perspectives and potentials.

Paper Citation

in Harvard Style

Xu Z. (2025). N6-methyladenosine Modifications in Cervical Cancer: The Molecular and Clinical Perspective. In Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS; ISBN 978-989-758-789-4, SciTePress, pages 281-286. DOI: 10.5220/0014486600004933

in Bibtex Style

@conference{befs25,
author={Ziqi Xu},
title={N6-methyladenosine Modifications in Cervical Cancer: The Molecular and Clinical Perspective},
booktitle={Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS},
year={2025},
pages={281-286},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0014486600004933},
isbn={978-989-758-789-4},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Biomedical Engineering and Food Science - Volume 1: BEFS
TI - N6-methyladenosine Modifications in Cervical Cancer: The Molecular and Clinical Perspective
SN - 978-989-758-789-4
AU - Xu Z.
PY - 2025
SP - 281
EP - 286
DO - 10.5220/0014486600004933
PB - SciTePress